OSI Pharmaceuticals, LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 24231
 
  
 
C07D HETEROCYCLIC COMPOUNDS 17145
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 544
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4202
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9896730 Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatmentApr 25, 12Feb 20, 18[C12Q]
9371298 Processes for the preparation of isothiazole derivativesNov 10, 14Jun 21, 16[C07D]
9351974 Substituted pteridinones for the treatment of cancerNov 12, 12May 31, 16[A61K, C07D]
9244058 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitorsDec 12, 11Jan 26, 16[G01N]
9133224 Macrocyclic kinase inhibitorsNov 29, 11Sep 15, 15[A61K, C07F]
9096624 Amino pyrimidine anticancer compoundsJan 25, 13Aug 04, 15[A61K, C07F, C07D]
8884025 Processes for the preparation of isothiazole derivativesAug 02, 05Nov 11, 14[C07D]
8796455 Fused bicyclic mTOR inhibitorsFeb 15, 13Aug 05, 14[A61K, C07D, A61P]
8735405 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitorsApr 13, 12May 27, 14[A61K, A01N, C07D]
8586546 Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitorsFeb 10, 12Nov 19, 13[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0088,114 FUSED BICYCLIC KINASE INHIBITORSAbandonedMay 15, 12Mar 27, 14[C07D]
8653268 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitorsExpiredJan 11, 13Feb 18, 14[C07D]
8642834 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formationExpiredFeb 26, 10Feb 04, 14[A61K, G01N, A01K, A61P]
2014/0018,375 BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITORSAbandonedFeb 22, 13Jan 16, 14[G01N]
8592448 Substituted pyrrolo[2,3-b]-pyridines and -pyrazinesExpiredNov 19, 09Nov 26, 13[A61K]
8557814 mTOR inhibitor salt formsExpiredMar 18, 09Oct 15, 13[A61K, C07D]
2013/0261,306 PREPARATION OF C-PYRAZINE-METHYLAMINESAbandonedMay 23, 13Oct 03, 13[C07D]
2013/0253,197 FUSED BICYCLIC KINASE INHIBITORSAbandonedApr 30, 13Sep 26, 13[C07D]
8513415 -pyrazine-methylaminesExpiredApr 19, 10Aug 20, 13[C07D]
2013/0210,026 BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO KINASE INHIBITORSAbandonedFeb 15, 13Aug 15, 13[G01N]
8465912 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formationExpiredFeb 26, 10Jun 18, 13[C12Q, C12N]
2013/0137,975 PET IMAGINGAbandonedFeb 09, 11May 30, 13[A61K, A61B]
2013/0072,495 FUSED BICYCLIC KINASE INHIBITORSAbandonedMay 16, 11Mar 21, 13[A61K, C07D, A61P]
8383357 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitorsExpiredApr 13, 07Feb 26, 13[G01N]
8377636 Biological markers predictive of anti-cancer response to kinase inhibitorsExpiredApr 14, 08Feb 19, 13[G01N]
8367826 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitorsExpiredDec 01, 11Feb 05, 13[C07D]
2013/0005,733 COMBINATION ANTI-CANCER THERAPYAbandonedMar 09, 11Jan 03, 13[A61K, A61P]
2012/0329,826 SUBSTITUTED-5-AMINOPYRROLO/PYRAZOLOPYRIDINESAbandonedMar 03, 11Dec 27, 12[A61K, C07D, A61P]
2012/0220,595 Deuterated Tyrosine Kinase InhibitorsAbandonedNov 11, 10Aug 30, 12[A61K, C07D, A61P]
2012/0214,830 BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORS IN HEPATOCELLULAR CARCINOMAAbandonedFeb 22, 12Aug 23, 12[A61K, G01N, A61P, C40B]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.